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assumption of impractical unlimited vaccine supply, we developed a generalized 
methodology based on dynamic stochastic model utilizing the ﬂow of limited vaccine 
supply to the individuals between two mutually exclusive subgroups (e.g. different age 
groups or different risk groups) in order to examine the long term impact of different 
vaccination programs on overall health outcomes from the whole population. In 
this model, both age dependency and seasonality in FOI were explicitly considered. 
This study aims to answer two key questions: 1) what is the best vaccination strategy 
in order to attain maximal quantitative post-vaccination health beneﬁts among 
two subpopulations? and 2) how different structures of age-speciﬁc FOI’s inﬂuence 
our selection on the vaccinated population? Most of the time, one needs to have 
various parameter values in the models targeting spreading of infectious diseases in 
populations which cannot be estimated accurately. Therefore, a series of scenarios 
with different FOI’s, demographic structures, vaccine efﬁcacy and other model param-
eters were used in our simulation studies using this stochastic age-structured frame-
work. In summary, our study dynamically acquired both important biomedical and 
mathematical implications by successfully analyzing the current mass vaccination 
strategy, evaluating the effect of different prevention and intervention options, and 
served as an accurate basis for outcome research that may facilitate further cost- 
effectiveness analysis.
CONCEPTUAL PAPERS & RESEARCH ON METHODS – Patient-Reported 
Outcomes Studies
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OBJECTIVES: Diabetes Mellitus (DM) patients typically suffer from comorbid condi-
tions and disease-related macro- and microvascular complications which, in conjunc-
tion to demographic, anthropometric, clinical and treatment satisfaction variables, 
have a confounding effect on health-related quality of life. Therefore, discriminative 
ability of measuring instruments is important. Three preference-based utility instru-
ments were assessed in terms of their sensitivity to a common complication of diabetes,    
i.e. coronary heart disease (CHD).    METHODS: 319 Type II DM patients (62.4% 
female, mean age 65.3) were surveyed with the 15D, EQ-5D, SF-36 and the Diabetes 
Treatment Satisfaction Questionnaire (DTSQ). Independent variables including 
gender, age, years with diabetes, BMI, HbA1c, treatment satisfaction, and existence 
of hypertension, hyperlipidaemia, COPD, arthropathy, vascular disease, diabetic foot, 
retinopathy, neuropathy and nephropathy were introduced in univariate regression 
models to identify signiﬁcant predictors of 15D, EQ-5D and SF-6D utilities. RESULTS: 
DM patients with CHD (N  107, 61.7% female, mean age 71.0) reported lower 
utilities than DM patients without: 15D, 0.740 vs. 0.841; EQ-5D, 0.627 vs. 0.756; 
SF-6D, 0.708 vs. 0.775, (P  0.001 throughout). The regression models explained 
51.1%, 39.6% and 28.0% of 15D, EQ-5D and SF-6D variance respectively. Five 
common signiﬁcant predictors (gender, age, treatment satisfaction, arthropathy and 
diabetic foot), and ﬁve others signiﬁcant in at least one model were identiﬁed, which 
were controlled for with ANCOVA. The respective results (CHD, yes vs. no) were: 
15D, 0.787 vs. 0.817, P  0.05; EQ-5D, 0.702 vs. 0.718, P  0.589; SF-6D, 0.737 
vs. 0.761, P  0.084. CONCLUSIONS: After correcting for the confounding effect of 
common diabetes variables, only the 15D produced statistically signiﬁcant HRQoL 
differences between DM patients with and without CHD, most likely due to its richer 
descriptive system. This increased sensitivity is perhaps evidence in favour of the 15D 
in diabetics suffering from CHD, but concurrently emphasizes the need for further 
testing in larger and more diverse DM patient samples.
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OBJECTIVES: Experiences with generic health-related quality of life (HRQoL) instru-
ments in German rehabilitation facilities are very limited. The goal of this study was 
to assess the applicability of EQ-5D as part of the quality management system in a 
sample of neurological and orthopaedic patients. METHODS: The assessment was 
implemented as part of the regular optional patient satisfaction evaluation at the out-
patient rehabilitation facility in Bielefeld ( Germany). Neurological and orthopaedic 
patients were surveyed by questionnaire at the beginning (T1) and the end (T2) of 
rehabilitation treatment. The survey period was September to December of 2008. 
HRQoL was determined by the German version of EQ-5D self-report questionnaire 
(European tariff) and EQ-VAS (visual analogue scale). Wilcoxon signed-rank test was 
used for comparison of T1 and T2. RESULTS: In total, 99 patient cases (mean age 
of 52 years, 58% orthopaedic and 32% female) were included in the study. The mean 
of EQ-5D index score increased from 0.66 (SD  0.18) to 0.74 (SD  0.18) at the end 
of the rehabilitation (statistically signiﬁcant with p  0,001). Mean VAS utility value 
improved signiﬁcantly (p  0,001) from 0.57 (SD  0.21) at T1 to 0.69 (SD  0.19) 
at T2. The percentage of patients with any problems decreased for all ﬁve dimensions 
(mobility: 49% to 32%; self-care: 21% to 12%; usual activities: 66% to 48%; pain/
discomfort: 82% to 63%; anxiety/depression: 29% to 24%). CONCLUSIONS: EQ-
5D showed good sensitivity and practicability for generic measurement of rehabilita-
tion outcomes and could supplement existing compulsory quality management 
systems. A comparable and widely accepted assessment of outcome quality also would 
be of interest for payers (statutory health insurance and pension insurance), owners 
and patients.
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OBJECTIVES: To identify trends in patient completion patterns between two modes 
of administration for electronic patient reported outcome (ePRO) questionnaires. 
METHODSs: Retrospective review of eleven clinical research projects in which the 
patients were offered the option of completing daily questionnaires with one of two 
modes: an interactive voice response (IVR) system or a web-based response (IWR) 
system. Both systems were available to the patient at every assessment, independent 
of the mode used in prior assessment. RESULTS: In the 11 studies, data were available 
for 29,078 patients from 15 countries. On average patients completed 42 (min:1, 
max:1424) assessments during their study participation. Across the studies 2.6% of 
patients completed all assessments using only IWR and 68.5% of patients completed 
all assessments using only IVR. Of those patients using both modes (N  8408), only 
12.3% completed an IWR questionnaire more often than they completed an IVR 
questionnaire and fewer than 1% completed an equal number of IVR and IWR ques-
tionnaires. Younger patients (a25 years-old) completed more questionnaires using 
IWR (30.5% of their assessments) compared to older patients. Patients between 46 
and 65 years-old completed the fewest questionnaires using IWR (6.1% of their assess-
ments). Patients in Serbia (N  37) completed the most questionnaire using IWR 
(46.6% of their assessments). Patients in Czech Republic (N  28), Finland (N  7491), 
Italy (N  32), and New Zealand (N  7) completed the fewest questionnaires using 
IWR (5.0% of their assessments). CONCLUSIONS: Most patients completed their 
assessments using the IVR. Despite having the option, most patients did not alternate 
between modes to complete the assessments. Younger patients were more likely to 
complete the assessments using IWR. Further work is needed to evaluate whether the 
completion patterns are due to patient preference or driven by access to the chosen 
mode, particularly in some geographic regions.
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OBJECTIVES: To compare EQ-5D and SF-6D utilities in chronic heart failure (CHF) 
patients with varying levels of disease severity, proxied by the Duke Activity Status 
Index (DASI). METHODS: A consecutive sample (N  251) of CHF patients undergo-
ing elective cardiac surgery were surveyed with the EQ-5D, SF-36 and the DASI, with 
the latter used to perform a uniform 5-way split of the sample according to functional 
capacity. Association and level of agreement between instruments in each severity           
group were estimated with Pearson’s r and the intraclass correlation coefﬁcient (ICC) 
respectively. Paired-samples t-test was used to identify signiﬁcant score differences, 
which were regarded as minimally important differences (MID) when exceeding 0.03. 
In a linear regression model, the DASI score was used as an anchor of disease severity 
to identify a potential “crossover” point between EQ-5D and SF-6D utilities. 
RESULTS: EQ-5D and SF-6D were in agreement and strongly correlated over the 
entire sample (ICC  0.484, P  0.001 and r  0.647, P  0.001), but correlation 
varied within the DASI-based groups. In the less severe groups (higher functional 
capacity) EQ-5D scores were signiﬁcantly higher than SF-6D scores (P  0.001) and 
differences constituted MIDs. Contrarily, in the more severe groups SF-6D was pre-
dominantly higher than EQ-5D. The regression model indicated a utility crossover 
point at 0.716 and predicted that individuals with a utility score less than this would 
score higher on the SF-6D than on the EQ-5D, and vice versa. The DASI score at 
crossover was calculated at 31.99. CONCLUSIONS: In subgroups of patients differing     
in CHF severity, mean EQ-5D and SF-6D indices differed signiﬁcantly, implying that 
the two instruments are not interchangeable and the choice of instrument for measur-
ing health-related utility can lead to variations in cost-utility analyses. Based on evi-
dence provided here, discrepancies in the instruments’ measuring range generate utility 
differences which require further investigation.
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Hand-foot syndrome or palmar-plantar erythrodysesthesia is a common adverse effect 
of certain chemotherapy agents, such as capecitabine or pegylated doxorubicin, where 
it is estimated to occur in 50% of cases. However, there is no speciﬁc, validated clinical 
instrument to measure its intensity and its impact on patients, apart from NCI-CTC 
grading which is relatively insensitive and is not speciﬁc. OBJECTIVES: The aim 
of this study is to develop and validate a hand-foot syndrome-speciﬁc quality of life 
scale in order to be able to measure the impact of the condition on patients and secondly 
to be able to assess the value of certain speciﬁc treatments in this indication. METHODS: 
The questionnaire was developed after conducting a series of structured interviews 
